No Data
No Data
No Data
Analysts Have Conflicting Sentiments on These Healthcare Companies: ARS Pharmaceuticals (SPRY), AnaptysBio (ANAB) and Allakos (ALLK)
Allakos Inc. Reports Increased Losses in Q1 2024, Misses Analyst Earnings Predictions
NOTV, BFRI and CPOP Among Pre-market Losers
Analysts Have Conflicting Sentiments on These Healthcare Companies: Electrocore (ECOR), Disc Medicine (IRON) and Allakos (ALLK)
Barclays Sticks to Its Sell Rating for Allakos (ALLK)
Allakos Buy Rating: Clinical Promise and Financial Stability Drive Positive Outlook
No Data